Peter Nygren

9.2k total citations
234 papers, 7.0k citations indexed

About

Peter Nygren is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Peter Nygren has authored 234 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Oncology, 93 papers in Molecular Biology and 35 papers in Surgery. Recurrent topics in Peter Nygren's work include Cancer therapeutics and mechanisms (25 papers), Cancer Treatment and Pharmacology (24 papers) and Intraperitoneal and Appendiceal Malignancies (22 papers). Peter Nygren is often cited by papers focused on Cancer therapeutics and mechanisms (25 papers), Cancer Treatment and Pharmacology (24 papers) and Intraperitoneal and Appendiceal Malignancies (22 papers). Peter Nygren collaborates with scholars based in Sweden, United States and Norway. Peter Nygren's co-authors include Rolf Larsson, Joachim Gullbo, Bengt Glimelius, Mårten Fryknäs, Ingrid Glimelius, Jonas Bergh, Malin Wickström, Haile Mahteme, Elin Lindhagen and Jörgen Kristensen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Peter Nygren

231 papers receiving 6.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Nygren 2.8k 2.7k 999 885 768 234 7.0k
Jerry M. Collins 2.7k 1.0× 3.1k 1.2× 893 0.9× 886 1.0× 1.3k 1.7× 176 9.0k
Nanno H. Mulder 2.2k 0.8× 3.4k 1.3× 1.4k 1.4× 592 0.7× 935 1.2× 229 6.9k
Giuseppe Toffoli 3.9k 1.4× 3.1k 1.1× 549 0.5× 1.1k 1.3× 922 1.2× 337 8.8k
Kees Nooter 3.9k 1.4× 5.4k 2.0× 899 0.9× 535 0.6× 699 0.9× 149 9.1k
Sharon Marsh 2.9k 1.1× 3.0k 1.1× 418 0.4× 708 0.8× 648 0.8× 109 6.7k
Zahid H. Siddik 3.8k 1.4× 4.6k 1.7× 776 0.8× 852 1.0× 1.1k 1.4× 154 9.4k
Youcef M. Rustum 3.5k 1.3× 3.7k 1.4× 865 0.9× 1.1k 1.2× 1.3k 1.7× 246 8.2k
Ali Shamseddine 1.6k 0.6× 2.3k 0.9× 965 1.0× 1.1k 1.2× 1.1k 1.4× 249 5.6k
Hilde Rosing 4.6k 1.7× 6.7k 2.5× 854 0.9× 786 0.9× 1.5k 2.0× 422 13.3k
David Chia 3.7k 1.3× 1.6k 0.6× 1.7k 1.7× 1.6k 1.8× 1.5k 2.0× 146 9.0k

Countries citing papers authored by Peter Nygren

Since Specialization
Citations

This map shows the geographic impact of Peter Nygren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Nygren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Nygren more than expected).

Fields of papers citing papers by Peter Nygren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Nygren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Nygren. The network helps show where Peter Nygren may publish in the future.

Co-authorship network of co-authors of Peter Nygren

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Nygren. A scholar is included among the top collaborators of Peter Nygren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Nygren. Peter Nygren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tabernero, Josep, Takayuki Yoshino, Sebastian Stintzing, et al.. (2023). A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial. Cancer Research Communications. 4(1). 28–37. 5 indexed citations
2.
3.
Fryknäs, Mårten, et al.. (2021). A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer. Scientific Reports. 11(1). 8981–8981. 25 indexed citations
4.
5.
6.
7.
Senkowski, Wojciech, Malin Jarvius, Jenny Rubin, et al.. (2016). Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids. Cell chemical biology. 23(11). 1428–1438. 28 indexed citations
8.
Månsson, C., et al.. (2016). Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy. European Journal of Surgical Oncology. 42(9). 1401–1406. 62 indexed citations
9.
Senkowski, Wojciech, Xiaonan Zhang, Maria Hägg Olofsson, et al.. (2015). Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer. Molecular Cancer Therapeutics. 14(6). 1504–1516. 118 indexed citations
10.
Kashif, Muhammad, Claes Andersson, Magnus Åberg, et al.. (2014). A Pragmatic Definition of Therapeutic Synergy Suitable for Clinically Relevant In Vitro Multicompound Analyses. Molecular Cancer Therapeutics. 13(7). 1964–1976. 16 indexed citations
11.
Cashin, Peter, W. Graf, Peter Nygren, & Haile Mahteme. (2011). Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case–control study. Annals of Oncology. 23(3). 647–652. 44 indexed citations
12.
Wickström, Malin, Rolf Larsson, Peter Nygren, & Joachim Gullbo. (2010). Aminopeptidase N (CD13) as a target for cancer chemotherapy. Cancer Science. 102(3). 501–508. 296 indexed citations
13.
Byström, Per, Åke Berglund, Ulrike Garske, et al.. (2009). Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer. Annals of Oncology. 20(6). 1057–1061. 55 indexed citations
14.
Quartino, Angelica, Mats O. Karlsson, Agneta Freijs, et al.. (2007). Modeling of In Vitro Drug Activity and Prediction of Clinical Outcome in Acute Myeloid Leukemia. The Journal of Clinical Pharmacology. 47(8). 1014–1021. 5 indexed citations
15.
Palle, Josefine, Britt‐Marie Frost, Erik Forestier, et al.. (2005). Cellular drug sensitivity in MLL-rearranged childhood acute leukemia is correlated to partner genes and cell lineage : On behalf of the Nordic Society for Paediatric Haematology and Oncology. British Journal of Haematology. 129(2). 1 indexed citations
16.
Hedström, Mariann, Anders Kreuger, Gustaf Ljungman, Peter Nygren, & Louise von Essén. (2005). Accuracy of assessment of distress, anxiety, and depression by physicians and nurses in adolescents recently diagnosed with cancer. Pediatric Blood & Cancer. 46(7). 773–779. 43 indexed citations
17.
Lövborg, Henrik, et al.. (2001). Modulation of cell death and metabolic effects by 3-aminobenzamide in U-937 GTB cells exposed to CHS 828. Biochemical Pharmacology.
18.
Bergh, Jonas, P.-E. Jönsson, Bengt Glimelius, & Peter Nygren. (2001). A Systematic Overview of Chemotherapy Effects in Breast Cancer. Acta Oncologica. 40(2). 253–281. 156 indexed citations
19.
20.
Nygren, Peter, Rolf Larsson, Hans E. Johansson, Sver­ker Ljunghall, & Jonas Rastad. (1988). 1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcified Tissue International. 43(4). 213–218. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerry M. Collins Breakdown of academic impact, for papers by Nanno H. Mulder Breakdown of academic impact, for papers by Giuseppe Toffoli Breakdown of academic impact, for papers by Kees Nooter Breakdown of academic impact, for papers by Sharon Marsh Breakdown of academic impact, for papers by Zahid H. Siddik Breakdown of academic impact, for papers by Youcef M. Rustum Breakdown of academic impact, for papers by Ali Shamseddine Breakdown of academic impact, for papers by Hilde Rosing Breakdown of academic impact, for papers by David Chia
Rankless by CCL
2026